Sort
50,496 grants matching “lung cancer”
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$943,457William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Multiethnic Genome Scan of Metabolic Phenotypes
$943,323Loic Le Marchand · University Of Minnesota · P01 · FY2014 · CA
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
$943,287Julien Sage · Stanford University · R35 · FY2023 · CA
Nutrition Intervention Trials
$943,252Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
VALIDATION OF FAMILY HISTORY OF CANCER QUESTIONNAIRE
$943,237Westat, Inc. · N01 · FY2000 · PC
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$943,099Antonio Fojo · Basic Sciences · Z01 · FY2007 · CA
Spectrally resolved tomographic small-animal fluorescence imager
$942,932Dylan Bulseco · Cambridge Research And Instrumentation · R44 · FY2010 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2016 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2018 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2017 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2021 · CA
Bay Area Cancer Target Discovery and Development
$942,785Michael T McManus · University Of California, San Francisco · U01 · FY2024 · CA
The Boston University - UCLA Lung Cancer Biomarker Characterization Center
$942,572Marc Elliott Lenburg · Boston University Medical Campus · U2C · FY2023 · CA
DIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAI
$942,541University Of Southern California · R01 · FY2005 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$942,313Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$942,190Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2025 · CA
INVESTIGATING THE ROLE OF A NOVEL INHIBITORY RECEPTOR COMPLEX IN DRIVING T CELL DYSFUNCTION AND THERAPEUTIC RESISTANCE TOWARD IMMUNOTHERAPIES IN LUNG CANCER.
$942,000The Cleveland Clinic Foundation · · FY2022 · Defense Health Agency
Office of Cancer Genomics
$941,752Douglas R. Lowy · Office Of The Director, Nci · ZIA · FY2010 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$941,526Xihong Lin · Harvard School Of Public Health · R35 · FY2018 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$941,526Xihong Lin · Harvard School Of Public Health · R35 · FY2017 · CA
Molecular Mechanisms of TGF-beta Signaling Pathway
$941,483Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$941,406William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Commercialization of Magneto-Nanosensor Immunoassay Platform for Cancer Diagnosis
$940,623Manuel Luis Carbonell · Magarray, Inc. · R44 · FY2014 · CA
Commercialization of Magneto-Nanosensor Immunoassay Platform for Cancer Diagnosis
$940,623Manuel Luis Carbonell · Magarray, Inc. · R44 · FY2013 · CA
Commercialization of Magneto-Nanosensor Immunoassay Platform for Cancer Diagnosis
$940,623Manuel Luis Carbonell · Magarray, Inc. · R44 · FY2015 · CA